AI assistant
Sending…
Microbot Medical Inc. — Director's Dealing 2011
Jun 25, 2011
33819_dirs_2011-06-24_5aa9cc47-7108-408b-a240-c6efc143db27.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2011-06-23
Reporting Person: WEISSMAN IRVING (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-06-23 | Common Stock | A | 1110 | $0.25 | Acquired | 357510 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 190111 | Indirect |
Footnotes
F1: The $0.25 per share price was the stock option exercise price for shares granted to Dr. Weissman on June 29, 2001 and July 1, 2001.
F2: Includes anniversary equity grant of 10,000 restricted stock units, vesting 100% on October 1, 2011, the one year anniversary of the grant.
F3: 105,079 shares held in trust as to which Dr. Weissman disclaims beneficial ownership.
More from Microbot Medical Inc.
Regulatory Filings
2026
Jun 2
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 15
Earnings Release
2026
May 14
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 5
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 13